Information from the Hunan Provincial Department of Health shows that in 2011, the price of successful drugs in Hunan Province fell by 30% compared with the current price of a class of hospitals in the province. It is expected that the drug burden for the people will be reduced by about 2.5 billion yuan a year. Buying a reasonably priced drug has always been the public’s expectation, but in May last year, the ex-factory price was only 15.5 yuan, the hospital sold the patient at a price of 213 yuan, and asparagus tablets with a profit of 1300% were exposed to public view. It is much more difficult to realize this public expectation than we have imagined.
How did Hunan achieve it?
Starting from December 31, 2010, public medical institutions in all counties and above in Hunan Province will purchase the winning bids through the provincial centralized drug procurement trading platform, and all centralized drug purchases in the original city and state will be stopped. County and above Public medical institutions must no longer purchase medicines for any reason and method.
This newspaper reported on May 28th, 2010, “Whoever broke the interest chain of high drug prices,†and the experts pointed out: “The key is the problem of institutional mechanisms, especially the centralized bidding and procurement system for drugs. The tendering system has actually become a The accomplice of high drug prices, this bizarre counter-phishing effect, it is worth pondering."
In Hunan, it is precisely in the drug bidding and procurement system that creatively moves the "surgery" and is known as the "Hunan model" for solving the problem of high drug prices.
Hunan model later came from Suzhou Aiye Pharmaceutical Co., Ltd. production of amoxicillin (lyophilized powder, specifications 2g), the original purchase price of 17.65 yuan, the original sales price of 20.3 yuan, is now bidding price of 8 yuan, the current retail price of 10.6 yuan.
Cefuroxime produced by Livzon Group (freeze-dried powder, size 750mg), the original purchase price of 15 yuan, the original sales price of 17.25 yuan, is now bidding price of 3.5 yuan, the current retail price of 4.3 yuan.
Cefpiramide produced in Beijing Pacific (injected powder, specifications 1g), the original purchase price of 75 yuan, the original sales price of 86.25 yuan, the current price of 16.5 yuan, the current retail price of 20.5 yuan.
Pazufloxacin (Specification 100mg: 2ml) produced by Laimei, Chongqing, the original purchase price of 28 yuan, the original sales price of 32.2 yuan, the current bid price is 12.1 yuan, and the current retail price is 15.5 yuan. . . . . .
The statistics from the Provincial Price Bureau show that after December 31, 2010, ordinary people can get uniform and affordable medicine regardless of their access to public medical institutions in all counties and counties in Hunan Province.
Since the ministries and commissions of the Ministry of Public Health and the State Council Corrective Office have implemented government-led centralized procurement of drugs across the country from the provincial level, by the end of 2008, 24 provinces across the country have successively established the centralized procurement system for medicines based on the provincial level. Hunan Province is a job One of the 6 provinces that started later.
Therefore, it is not an exaggeration to describe the Hunan model with “come-in†and “blockbusterâ€.
Tang Ling, director of the Drug Centralized Bidding and Procurement Office of the Hunan Provincial Department of Health, is an important participant in the centralized procurement of drugs. Tang Ling had previously worked in Xiangya Hospital, and was specialized in pharmacy management. In January 2009, the leaders sought him to talk and hoped to use his advantages to commit himself to the reform of centralized drug price procurement.
Tang Ling considered that if Hunan wants to turn from backward to advanced, then it must be innovative in the model.
According to Tang Ling, when designing a specific plan, the results of the Provincial Joint Conference on Drug Concentration Purchasing held that the reform must achieve three goals and regulate the current problem of opaque, undisclosed, and unconcentrated forms of procurement; lower prices of medicines. Relieve the expensive problem of visiting the doctor; the third is to reflect public welfare in the aspect of tendering fees.
Facts have proved that the "Hunan Model" firmly holds these three purposes.
The basic medicines were subject to centralized tendering, and the successful bidder was one of the provinces with the largest number of basic drug bids in the country; the bid price was 53.21% lower than the guideline price for basic drugs announced by the National Development and Reform Commission, and was at a lower level in the country; according to the State Council's Health Reform Office, the provinces A sample survey was conducted on the tender prices of essential medicines. The results showed that only the winning bid prices for all sampled drugs in Hunan, Guizhou, and Shaanxi were below the median price.
The centralized procurement of drugs in Hunan Province has also been affirmed by the State Council Correction Office and the Ministry of Health, and a typical speech was made at the National Drug Concentration Sourcing Conference in 2010.
The Six Major Characteristics Adjusting the Pattern of Interests in the Pharmaceutical Market The interest chain behind the high drug prices is intricate and complicated. The “Hunan Model†benefits from the government-centric reforms that are the first to persist.
“Because of price cuts in tenders, manufacturers, distribution companies, and hospitals are unwilling, only ordinary people are willing to, then who will help the people to speak? Only the government. And the reform is the restructuring of interests, it is difficult to do without the government-led.†Deputy Commissioner of the Commission for Discipline Inspection, Huang Lifeng introduced the rectification room.
The other five characteristics form a joint force outside the central point of "government-led", namely, departmental linkage, separation of management and procurement, free trade, transparency, and benefiting the people."
"The reform involves many departments. The joint conference system is a platform for departmental linkage and can make effective decisions in a timely manner." Tang Ling said.
Concentration of power leads to corruption, and how to achieve control, procurement, supervision of the three power constraints and balance? The Hunan model set up a three-pronged approach.
In the establishment of the organization, the Hunan Province Wind Corrections Office took the lead in establishing the Provincial Drug Centralized Purchase Supervision Committee composed of 11 related departments such as health, development and reform, commodity prices, and pharmaceutical supervisors to take charge of the supervision of centralized drug procurement in the province. The Office of the Supervisory Committee was set up in the Provincial Commission for Corrective Action, and the joint conference office was set up in the Provincial Health Department, realizing the separation of supervision in the true sense. The power of procurement transactions was placed in the bidding center of the Provincial Development and Reform Commission.
In order to ensure the fair and equitable procurement of drugs, the provincial rectification office together with the members of the Provincial Drug Centralized Purchase Supervision Committee participated in the supervision of the entire process and explored the establishment of a supervision mechanism for centralized drug procurement.
Huang Lifeng said, “The comrades who have been identified by the disciplinary inspection and supervision of the relevant departments are serving as supervisors. In the past, the person in charge of the business unit of the member unit of the Drug Centralized Purchase Joint Meeting served as the liaison officer and supervisor. Both as an athlete and as a referee, supervision could not really be put in place. Now it is replaced by the responsible comrades of the supervision department of the relevant departments to serve as supervisors, and has truly played the role of supervision of disciplinary inspection and supervision agencies.
It is understood that after publicizing the results of the examination of the quality procurement bidders' qualifications, the Provincial Correctional Service Office has received reports to reflect that some companies provide European and American certifications and other false materials. The office supervises the pharmaceutical supervision department to organize experts to identify 741 European and American certifications that the original audits have confirmed. The rules and regulations of the product have undergone a focused review and rigorous review, eventually retaining the so-called European and American accreditation qualifications for 187 products, canceling 554 European and American accreditations for product specifications, and publishing an “emergency notice requiring bidders to withdraw false materials within a time limitâ€. , to ensure that the centralized procurement of drugs is fair and just.
Another highlight is the free trade policy. The general practice is that enterprises need to charge a certain amount of management fees for bidding, while Hunan is completely free.
Some people say that when they bid, they can collect fees and don’t collect any money, which can ease the pressure of increasing fiscal revenue. I’m sure I can’t collect money, so I’m clean. This is a public welfare undertaking that benefits the entire province. We must ensure fairness and justice, "said Tang Ling to the Legal Weekly reporter.
During the process of bargaining, Wichou fought bravely from September 20 to 30, 2010. In 2010, the province’s public medical institutions at and above the county level in the province were confined to Changsha for the centralized procurement of drugs.
"This is a long-lasting process of wits and wits." Huang Lifeng described. "Pharmaceutical manufacturers may try to keep their prices down, and they may find some loopholes in certain systems."
At the meeting on the evening of the meeting, the supervisors reported that some experts in the bargaining group had misunderstood the bargaining rules, resulting in generally high bargaining drug prices. The supervision team timely read the raw data of the group’s bargaining price and organized related personnel to carry out serious inspections. An emergency meeting was held to discuss until about one o'clock in the morning. It was decided to establish a daily rotation and data review system for the bargaining team.
"The daily rotation of the bargaining team is to prevent bargaining experts and private drug manufacturers from making private exchanges, eliminating the act of accepting bribery and ensuring the impartiality of bid evaluation," said Huang Lifeng. The bid evaluation work was very meaningful because of the arrival of the two leaders.
On the morning of September 24th, Xu Yunzhao, member of the Standing Committee of the Provincial Party Committee and Secretary of the Provincial Discipline Inspection Committee, went to the bid evaluation site for inspection and guidance.
On September 26, Vice Governor Guo Liang arrived at the scene to guide his work.
How to determine a reasonable drug bid price is a key link in the centralized procurement of drugs. In order to avoid inflated drug prices, the Hunan Model established several thresholds for price determination. The first step is to limit prices, formulate guidance prices for bids for centralized procurement of pharmaceuticals, and then bid and bargain for the second step.
"We have learned that Sichuan Province requires all companies that meet the price limit to be able to come in. We will use this limit price approach. But Henan is not the same. It does not impose price limits, but engages in bid evaluation. We further In the Guangdong Province, they engaged in bidding, and one company quotation came in. After taking these provinces' plans, combined with Hunan's own situation, we only had the mode of price-bidging and bargaining before the limit price was reached, "said Huang Lifeng.
After a large number of preliminary investigations, the expert group determined the "guidance price" for more than 30,000 drugs, that is, the quotation price. All drugs participating in the bid must be limited to the guide price. The determination of the guiding price first follows the principle of “five not higher thanâ€: one is not higher than the highest retail price issued by the National Development and Reform Commission and the Provincial Price Bureau; the second is not more than the average purchase price of 38 first class hospitals in the province The third is that the patents, original research, separate pricing, and high-quality and high-priced drugs are not higher than the average bid price of the province's and the six provinces and regions in the previous procurement year; the fourth is the price quoted by the general GMP quality drug bidding is not higher than the province and The highest price among the lowest bid prices of the same drug at the same year for the six provinces and districts in the last year of purchase; the fifth is the average retail price of drugs for large retail pharmacies in the province. On this basis, according to the principle of "respectively low to high", the bidding price of drugs is determined.
A total of 24,331 drug quotes were valid through on-site bid opening and remote bid opening. Through auctions and bargaining, the review experts selected about 15015 high-quality and inexpensive drugs from these drugs as successful bidders, and the successful rate was about 62%. From the aspect of the quality level and variety specifications of the winning bidder, it can meet the clinical use of non-profit medical institutions in counties and counties across the province.
Instigating the high price chain for drug prices On January 25, 2011, the reporter went into the Hunan Provincial Bidding and Exchange Center. Nie Jinjing, chief of the drug procurement department, expressed his emotions when he recalled the establishment of a centralized drug procurement trading platform. The platform worked eight positions. The staff completed 20 people's workload.
“All aspects of bid registration, prequalification, quotation, bid opening, bidding, bargaining, and drug purchase transactions are all completed through the platform; information on drug catalogs, guide prices, audit results, company quotes, and successful bid results are all displayed on the platform; Various functional departments can implement online monitoring, data aggregation and analysis of drug procurement and use of medical institutions throughout the province through the platform.†Wang Guangming, Director of the Provincial Development and Reform Commission Bidding Center, briefed the Legal Weekly reporter.
Xiao Gucheng, Director of the Price Control Department of the Provincial Price Bureau, explained to the reporter that the drug prices displayed on the trading platform are actually the prices formed by the direct transactions of medical institutions as the winning bid prices, and the medical institutions used the winning bid price as the actual purchase price. The cost of participating in the centralized procurement of medical institutions in the province is included in the bid price.
The calculation method for the retail price of pharmaceuticals purchased by medical institutions is: retail price of medical institutions = actual purchase price (ie, the bid price of pharmaceutical companies) × (1 + differential circulation rate) + adjustment balance. The actual purchase price refers to the price of the smallest unit of a certain drug for complete packaging, in which the injection takes the bottle or bottle as the minimum unit of measurement, and other dosage forms use the current minimum package as the unit of measurement, such as boxes and bottles.
"This is a crucial first step in Hunan's efforts to cut drug prices. Overall, it works well. But we must also see that our centralized drug procurement system is because the price system of drugs is not perfect." The supply and demand system for drugs has been seriously oversupplied, and the price of drugs is far greater than its own value. This does not conform to the economic laws of the market, so it is not an eternal business. When one day, its price is in line with its own Value, supply and demand are considerable, then at that time there will be no centralized procurement of drugs, leaving only one information platform to exist, the transaction between the purchaser and the supplier, and the platform for public disclosure. Ling expressed his thoughts to reporters. "In fact, it is an adjustment of the pattern of interests. The government departments come out to speak for the people."
Xiao Gucheng believes that it is necessary to guard against the use of another new drug to replace the production companies after bidding and bidding. "In fact, it is a change of drugs. The United States has only about ten new drugs a year, and China has several thousand a year. “
He went on to say that doctors used kickbacks, and that “secondary bargaining†and the limited financial subsidies of medical institutions are all problems. Therefore, it is still very long to cut the path of high drug prices.
"The final bidding for Hunan was like a bone stuck in the throat, spit reluctantly, and it was difficult to swallow it after eating." Tang Ling described the feelings of drug manufacturers. "This is due to the impartial, fair and strict supervision of the Hunan model."
In last year's county and county-level or above public medical institutions, the majority of experts were threatened by certain corporate personnel. A specialist was even tracked by two big men. After the work was over, it was supposed to be easy to hold. He burst into tears.
“It shows that companies have no way to go. To enter the market in Hunan, we must follow the principle of our 'five no more than' principle. In fact, we have cut down the circulation area where the drug prices are high, because it is quite Of the drug price component of some drugs, 80% is the cost of circulation.
Tang Ling accidentally received a couplet gift from a pharmaceutical production company after completing the centralized procurement bid evaluation.
"On the joint: sharp knife, blood flow into the river. The next link: fair and just, helpless. Cross-batch: Hunan centralized procurement of drugs."
How did Hunan achieve it?
Starting from December 31, 2010, public medical institutions in all counties and above in Hunan Province will purchase the winning bids through the provincial centralized drug procurement trading platform, and all centralized drug purchases in the original city and state will be stopped. County and above Public medical institutions must no longer purchase medicines for any reason and method.
This newspaper reported on May 28th, 2010, “Whoever broke the interest chain of high drug prices,†and the experts pointed out: “The key is the problem of institutional mechanisms, especially the centralized bidding and procurement system for drugs. The tendering system has actually become a The accomplice of high drug prices, this bizarre counter-phishing effect, it is worth pondering."
In Hunan, it is precisely in the drug bidding and procurement system that creatively moves the "surgery" and is known as the "Hunan model" for solving the problem of high drug prices.
Hunan model later came from Suzhou Aiye Pharmaceutical Co., Ltd. production of amoxicillin (lyophilized powder, specifications 2g), the original purchase price of 17.65 yuan, the original sales price of 20.3 yuan, is now bidding price of 8 yuan, the current retail price of 10.6 yuan.
Cefuroxime produced by Livzon Group (freeze-dried powder, size 750mg), the original purchase price of 15 yuan, the original sales price of 17.25 yuan, is now bidding price of 3.5 yuan, the current retail price of 4.3 yuan.
Cefpiramide produced in Beijing Pacific (injected powder, specifications 1g), the original purchase price of 75 yuan, the original sales price of 86.25 yuan, the current price of 16.5 yuan, the current retail price of 20.5 yuan.
Pazufloxacin (Specification 100mg: 2ml) produced by Laimei, Chongqing, the original purchase price of 28 yuan, the original sales price of 32.2 yuan, the current bid price is 12.1 yuan, and the current retail price is 15.5 yuan. . . . . .
The statistics from the Provincial Price Bureau show that after December 31, 2010, ordinary people can get uniform and affordable medicine regardless of their access to public medical institutions in all counties and counties in Hunan Province.
Since the ministries and commissions of the Ministry of Public Health and the State Council Corrective Office have implemented government-led centralized procurement of drugs across the country from the provincial level, by the end of 2008, 24 provinces across the country have successively established the centralized procurement system for medicines based on the provincial level. Hunan Province is a job One of the 6 provinces that started later.
Therefore, it is not an exaggeration to describe the Hunan model with “come-in†and “blockbusterâ€.
Tang Ling, director of the Drug Centralized Bidding and Procurement Office of the Hunan Provincial Department of Health, is an important participant in the centralized procurement of drugs. Tang Ling had previously worked in Xiangya Hospital, and was specialized in pharmacy management. In January 2009, the leaders sought him to talk and hoped to use his advantages to commit himself to the reform of centralized drug price procurement.
Tang Ling considered that if Hunan wants to turn from backward to advanced, then it must be innovative in the model.
According to Tang Ling, when designing a specific plan, the results of the Provincial Joint Conference on Drug Concentration Purchasing held that the reform must achieve three goals and regulate the current problem of opaque, undisclosed, and unconcentrated forms of procurement; lower prices of medicines. Relieve the expensive problem of visiting the doctor; the third is to reflect public welfare in the aspect of tendering fees.
Facts have proved that the "Hunan Model" firmly holds these three purposes.
The basic medicines were subject to centralized tendering, and the successful bidder was one of the provinces with the largest number of basic drug bids in the country; the bid price was 53.21% lower than the guideline price for basic drugs announced by the National Development and Reform Commission, and was at a lower level in the country; according to the State Council's Health Reform Office, the provinces A sample survey was conducted on the tender prices of essential medicines. The results showed that only the winning bid prices for all sampled drugs in Hunan, Guizhou, and Shaanxi were below the median price.
The centralized procurement of drugs in Hunan Province has also been affirmed by the State Council Correction Office and the Ministry of Health, and a typical speech was made at the National Drug Concentration Sourcing Conference in 2010.
The Six Major Characteristics Adjusting the Pattern of Interests in the Pharmaceutical Market The interest chain behind the high drug prices is intricate and complicated. The “Hunan Model†benefits from the government-centric reforms that are the first to persist.
“Because of price cuts in tenders, manufacturers, distribution companies, and hospitals are unwilling, only ordinary people are willing to, then who will help the people to speak? Only the government. And the reform is the restructuring of interests, it is difficult to do without the government-led.†Deputy Commissioner of the Commission for Discipline Inspection, Huang Lifeng introduced the rectification room.
The other five characteristics form a joint force outside the central point of "government-led", namely, departmental linkage, separation of management and procurement, free trade, transparency, and benefiting the people."
"The reform involves many departments. The joint conference system is a platform for departmental linkage and can make effective decisions in a timely manner." Tang Ling said.
Concentration of power leads to corruption, and how to achieve control, procurement, supervision of the three power constraints and balance? The Hunan model set up a three-pronged approach.
In the establishment of the organization, the Hunan Province Wind Corrections Office took the lead in establishing the Provincial Drug Centralized Purchase Supervision Committee composed of 11 related departments such as health, development and reform, commodity prices, and pharmaceutical supervisors to take charge of the supervision of centralized drug procurement in the province. The Office of the Supervisory Committee was set up in the Provincial Commission for Corrective Action, and the joint conference office was set up in the Provincial Health Department, realizing the separation of supervision in the true sense. The power of procurement transactions was placed in the bidding center of the Provincial Development and Reform Commission.
In order to ensure the fair and equitable procurement of drugs, the provincial rectification office together with the members of the Provincial Drug Centralized Purchase Supervision Committee participated in the supervision of the entire process and explored the establishment of a supervision mechanism for centralized drug procurement.
Huang Lifeng said, “The comrades who have been identified by the disciplinary inspection and supervision of the relevant departments are serving as supervisors. In the past, the person in charge of the business unit of the member unit of the Drug Centralized Purchase Joint Meeting served as the liaison officer and supervisor. Both as an athlete and as a referee, supervision could not really be put in place. Now it is replaced by the responsible comrades of the supervision department of the relevant departments to serve as supervisors, and has truly played the role of supervision of disciplinary inspection and supervision agencies.
It is understood that after publicizing the results of the examination of the quality procurement bidders' qualifications, the Provincial Correctional Service Office has received reports to reflect that some companies provide European and American certifications and other false materials. The office supervises the pharmaceutical supervision department to organize experts to identify 741 European and American certifications that the original audits have confirmed. The rules and regulations of the product have undergone a focused review and rigorous review, eventually retaining the so-called European and American accreditation qualifications for 187 products, canceling 554 European and American accreditations for product specifications, and publishing an “emergency notice requiring bidders to withdraw false materials within a time limitâ€. , to ensure that the centralized procurement of drugs is fair and just.
Another highlight is the free trade policy. The general practice is that enterprises need to charge a certain amount of management fees for bidding, while Hunan is completely free.
Some people say that when they bid, they can collect fees and don’t collect any money, which can ease the pressure of increasing fiscal revenue. I’m sure I can’t collect money, so I’m clean. This is a public welfare undertaking that benefits the entire province. We must ensure fairness and justice, "said Tang Ling to the Legal Weekly reporter.
During the process of bargaining, Wichou fought bravely from September 20 to 30, 2010. In 2010, the province’s public medical institutions at and above the county level in the province were confined to Changsha for the centralized procurement of drugs.
"This is a long-lasting process of wits and wits." Huang Lifeng described. "Pharmaceutical manufacturers may try to keep their prices down, and they may find some loopholes in certain systems."
At the meeting on the evening of the meeting, the supervisors reported that some experts in the bargaining group had misunderstood the bargaining rules, resulting in generally high bargaining drug prices. The supervision team timely read the raw data of the group’s bargaining price and organized related personnel to carry out serious inspections. An emergency meeting was held to discuss until about one o'clock in the morning. It was decided to establish a daily rotation and data review system for the bargaining team.
"The daily rotation of the bargaining team is to prevent bargaining experts and private drug manufacturers from making private exchanges, eliminating the act of accepting bribery and ensuring the impartiality of bid evaluation," said Huang Lifeng. The bid evaluation work was very meaningful because of the arrival of the two leaders.
On the morning of September 24th, Xu Yunzhao, member of the Standing Committee of the Provincial Party Committee and Secretary of the Provincial Discipline Inspection Committee, went to the bid evaluation site for inspection and guidance.
On September 26, Vice Governor Guo Liang arrived at the scene to guide his work.
How to determine a reasonable drug bid price is a key link in the centralized procurement of drugs. In order to avoid inflated drug prices, the Hunan Model established several thresholds for price determination. The first step is to limit prices, formulate guidance prices for bids for centralized procurement of pharmaceuticals, and then bid and bargain for the second step.
"We have learned that Sichuan Province requires all companies that meet the price limit to be able to come in. We will use this limit price approach. But Henan is not the same. It does not impose price limits, but engages in bid evaluation. We further In the Guangdong Province, they engaged in bidding, and one company quotation came in. After taking these provinces' plans, combined with Hunan's own situation, we only had the mode of price-bidging and bargaining before the limit price was reached, "said Huang Lifeng.
After a large number of preliminary investigations, the expert group determined the "guidance price" for more than 30,000 drugs, that is, the quotation price. All drugs participating in the bid must be limited to the guide price. The determination of the guiding price first follows the principle of “five not higher thanâ€: one is not higher than the highest retail price issued by the National Development and Reform Commission and the Provincial Price Bureau; the second is not more than the average purchase price of 38 first class hospitals in the province The third is that the patents, original research, separate pricing, and high-quality and high-priced drugs are not higher than the average bid price of the province's and the six provinces and regions in the previous procurement year; the fourth is the price quoted by the general GMP quality drug bidding is not higher than the province and The highest price among the lowest bid prices of the same drug at the same year for the six provinces and districts in the last year of purchase; the fifth is the average retail price of drugs for large retail pharmacies in the province. On this basis, according to the principle of "respectively low to high", the bidding price of drugs is determined.
A total of 24,331 drug quotes were valid through on-site bid opening and remote bid opening. Through auctions and bargaining, the review experts selected about 15015 high-quality and inexpensive drugs from these drugs as successful bidders, and the successful rate was about 62%. From the aspect of the quality level and variety specifications of the winning bidder, it can meet the clinical use of non-profit medical institutions in counties and counties across the province.
Instigating the high price chain for drug prices On January 25, 2011, the reporter went into the Hunan Provincial Bidding and Exchange Center. Nie Jinjing, chief of the drug procurement department, expressed his emotions when he recalled the establishment of a centralized drug procurement trading platform. The platform worked eight positions. The staff completed 20 people's workload.
“All aspects of bid registration, prequalification, quotation, bid opening, bidding, bargaining, and drug purchase transactions are all completed through the platform; information on drug catalogs, guide prices, audit results, company quotes, and successful bid results are all displayed on the platform; Various functional departments can implement online monitoring, data aggregation and analysis of drug procurement and use of medical institutions throughout the province through the platform.†Wang Guangming, Director of the Provincial Development and Reform Commission Bidding Center, briefed the Legal Weekly reporter.
Xiao Gucheng, Director of the Price Control Department of the Provincial Price Bureau, explained to the reporter that the drug prices displayed on the trading platform are actually the prices formed by the direct transactions of medical institutions as the winning bid prices, and the medical institutions used the winning bid price as the actual purchase price. The cost of participating in the centralized procurement of medical institutions in the province is included in the bid price.
The calculation method for the retail price of pharmaceuticals purchased by medical institutions is: retail price of medical institutions = actual purchase price (ie, the bid price of pharmaceutical companies) × (1 + differential circulation rate) + adjustment balance. The actual purchase price refers to the price of the smallest unit of a certain drug for complete packaging, in which the injection takes the bottle or bottle as the minimum unit of measurement, and other dosage forms use the current minimum package as the unit of measurement, such as boxes and bottles.
"This is a crucial first step in Hunan's efforts to cut drug prices. Overall, it works well. But we must also see that our centralized drug procurement system is because the price system of drugs is not perfect." The supply and demand system for drugs has been seriously oversupplied, and the price of drugs is far greater than its own value. This does not conform to the economic laws of the market, so it is not an eternal business. When one day, its price is in line with its own Value, supply and demand are considerable, then at that time there will be no centralized procurement of drugs, leaving only one information platform to exist, the transaction between the purchaser and the supplier, and the platform for public disclosure. Ling expressed his thoughts to reporters. "In fact, it is an adjustment of the pattern of interests. The government departments come out to speak for the people."
Xiao Gucheng believes that it is necessary to guard against the use of another new drug to replace the production companies after bidding and bidding. "In fact, it is a change of drugs. The United States has only about ten new drugs a year, and China has several thousand a year. “
He went on to say that doctors used kickbacks, and that “secondary bargaining†and the limited financial subsidies of medical institutions are all problems. Therefore, it is still very long to cut the path of high drug prices.
"The final bidding for Hunan was like a bone stuck in the throat, spit reluctantly, and it was difficult to swallow it after eating." Tang Ling described the feelings of drug manufacturers. "This is due to the impartial, fair and strict supervision of the Hunan model."
In last year's county and county-level or above public medical institutions, the majority of experts were threatened by certain corporate personnel. A specialist was even tracked by two big men. After the work was over, it was supposed to be easy to hold. He burst into tears.
“It shows that companies have no way to go. To enter the market in Hunan, we must follow the principle of our 'five no more than' principle. In fact, we have cut down the circulation area where the drug prices are high, because it is quite Of the drug price component of some drugs, 80% is the cost of circulation.
Tang Ling accidentally received a couplet gift from a pharmaceutical production company after completing the centralized procurement bid evaluation.
"On the joint: sharp knife, blood flow into the river. The next link: fair and just, helpless. Cross-batch: Hunan centralized procurement of drugs."
Organic Pet Food,Bio Pet Food,Natural Pet Food,Dry Dog Food
Jiangxi Welton Pet Products Co., Ltd. , https://www.weltonpetcare.com